Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Incyte Corporation INCY

Healthcare  —  Biotechnology
123.20 (1.62) (1.30%) as of 29 Sep
Market cap
$26.1B
P/E
15.4×
S&P 500 Member Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Incyte Corporation (INCY) P/S ratio

As of 28 September 2026, Incyte Corporation (INCY) trades at a P/S ratio of 4.3×. Over the past ten years it has ranged from 2.4× (April 2025) to 36.5× (September 2015); the current reading is higher than 28% of that period. That is below the Biotechnology industry median of 11.5× and above the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 3.8× 11.18%
FY2024 3.4× (14.84%)
FY2023 4.0× (23.87%)
FY2022 5.2× (3.98%)
FY2021 5.4× (23.83%)
FY2020 7.1× (18.18%)
FY2019 8.7× 21.13%
FY2018 7.2× (46.59%)
FY2017 13.4× (22.72%)
FY2016 17.4× (32.72%)

Quarterly

Period P/S ratio Change
Jun 2026 3.9× 11.53%
Mar 2026 3.5× (6.68%)
Dec 2025 3.8× 8.77%
Sep 2025 3.4× 19.66%
42 more quarters

Against its own ten years

Low 2.4× High 36.5×
Ten-year median 7.4×
Current reading's percentile 28

P/S ratio against peers

Company P/S ratio
JAZZ Jazz Pharmaceuticals PLC compare 3.3×
INCY Incyte Corporation 4.3×
GMAB Genmab A/S Sponsored ADR compare 5.3×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 6.7×
ALNY Alnylam Pharmaceuticals, Inc. compare 7.1×
BNTX BioNTech SE Sponsored ADR compare 8.3×
RPRX Royalty Pharma PLC compare 10.2×
INSM Insmed, Inc. compare 22.5×
ROIV Roivant Sciences Ltd. compare 3,539×
Biotechnology industry median 11.5×
Healthcare sector median 3.8×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on INCY